Uncovering the Gardasil HPV Vaccine

In 2009, the CDC’s latest report caught the eye of the mainstream media. Chief Medical Editor Dr. Timothy Johnson said that he, too, would encourage parents to learn more about the shot before getting their daughters vaccinated.

“I am very much in favor of childhood vaccines,” Johnson told Chris Cuomo on Wednesday’s “Good Morning America,” adding that there is little doubt that the vaccine does have its benefits.

“We know it does what it says – it prevents HPV infections,” he said.

But he added that when it comes to comparing the benefits of the HPV vaccine against its potential risks, he believes there simply is not enough evidence to recommend to all parents that they have their daughters vaccinated.

“I don’t think we yet know the long term benefits or risks,” Johnson said. “I’m taking a pass on this one and saying to parents, ‘Study the issue, read the editorial… talk to your doctor.'”

Editorial to which Dr. Johnson was referring: The Risks and Benefits of HPV Vaccination in the Journal of the American Medical Association from August 2009. The CDC’s report is allegedly buried inside the “The Risks and Benefits of HPV Vaccination”.

On the same day, the Marketing HPV Vaccine Implications for Adolescent Health and Medical Professionalism was published. Both give serious thought to the dangers of Gardasil, because HOPE has NEVER been the foundation of evidence-based medicine. Throwing HOPE into the practice can and has catastrophic consequences; as evidenced by the premature death of Christina Tarsell just 18 days after the first dose of the Gardasil HPV vaccine.



“MADRID, Feb 10 2009 – Spain’s Health Ministry has ordered hospitals and chemists to temporarily halt the use of a batch of cervical cancer vaccine Gardasil, produced by drugmaker Merck & Co (MRK.N), after two girls became ill after a shot.

Spain’s health ministry said health services would continue to administer shots of the vaccine but ordered that the use of batch NH52670 be suspended after health authorities in Valencia region reported on Feb. 6 that two girls had become ill after receiving the injection.”


Five Years Since the Suspension of Proactive Recommendation of the Human Papillomavirus (HPV) Vaccine in Japanhttps://www.hpv-yakugai.net/2018/06/29/5years-english

“It has been five years since the Japanese Government halted proactive recommendation of the HPV vaccine on June 14, 2013, claiming that it could not provide the public with enough information. Compared to other routine vaccinations, an average of over seven times the number of serious adverse effects per one million HPV vaccinations have been reported, and the number of disability certifications by the Adverse Drug Reaction Relief System is almost ten times higher. The government has put in place research groups and selected cooperating medical institutions for the HPV vaccine, but measures to prevent adverse effects and to provide treatment have yet to be established. The public cannot use the HPV vaccine with peace of mind.

The government officially endorsed the HPV vaccine nine years ago, and many of the victims who were junior or high school students at the time of their HPV vaccination have now grown into adults. However, they have received no effective medical treatment until now and suffer from serious adverse effects, not only pain spreading all over their bodies and involuntary movements, but perceptual disorders, impaired mobility, sleep disruption, impaired memory, and learning disabilities. While their classmates became working adults, they have been incapable of fully attending classes and have abandoned their plans for higher education or getting a job. With no medical institutions able to give them sufficient treatment, they see no bright future and live under a shadow of uncertainty as they struggle to cope with agonizing symptoms every day.”


“Almost 650 girls in Ireland reported requiring medical intervention or treatment after receiving the HPV vaccine, according to data collected by the State’s medicines watchdog.

“The Health Products Regulatory Authority has received 1,099 reports of adverse reactions and events associated with the use of the vaccine, but it said that this should not be taken as evidence of a causal link and that the benefits continue to outweigh the potential risks.

More than 690,000 doses
Since it was introduced in Ireland, in 2010, more than 690,000 doses of the vaccine have been distributed, and 230,000 girls have received the full course.

It said 59 per cent of the reports – or 648 cases – were considered serious, meaning they included circumstances where patients required intervention, such as a review by their GP, treatment for their symptoms, or both.”

Denmark- Are the Danes finally on to something?

“In 2014, Denmark experienced a rapid decline in vaccination uptake for the human papillomavirus (HPV) vaccine after a successful introduction of the vaccine in 2009. Before the decline, the uptake of the first HPV vaccine was around 90% for girls born in the period 1998 to 2000, while it dropped to 54% for girls born in 2003. The decline followed negative public attention from 2013 coinciding with increasing suspected adverse-event reporting to the Danish Medicines Agency. The aim of this study is to describe the HPV-vaccination uptake, to quantify relevant HPV-related media coverage, and analyse the relation between media coverage and HPV-vaccination acceptance in Denmark in year 2009–2016.”

Following a successful launch of the HPV-vaccination programme, concerns about vaccine safety shifted the public opinion and the coverage by the media. The noticeable shift in correlation between vaccination uptake and media coverage before and after July 2013 could indicate that increased media coverage influenced the decline in vaccination uptake. Media monitoring may represent an important tool in future monitoring and assessment of confidence in vaccination programmes.”

Also from the WHO Europe office dated January 28, 2019

Danish health authorities have launched a media campaign to restore public confidence in response to negative media reports questioning the safety of the human papillomavirus (HPV) vaccine and a related decline in the number of teenage girls getting it. The vaccine protects against cervical cancer.

“We knew that we had to do something to turn the trend around,” said Stine Ulendorf Jacobsen, a consultant with the Danish Health Authority. “We needed to raise public awareness by increasing health literacy so that people could make an informed medical choice about the vaccine.”

Does this suggest that the World Health Organization (WHO) is specifically targeting the countr(ies) who fall below the red line? What they are describing as “health literacy” can also be considered systematic manipulation?

I have said it before and I’ll say it again, Merck vs. the World when the Dam of information finally bursts… Some countries are catching on more than they were, but we need the entirety of Europe to take swift, definitive action before we see the “Gardasil Girls” (and boys!) to stop manufacturing this life-altering or life-ending junk.

UPDATED: 02/18/2020

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s